Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Nawarskas

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Heart Disease (Hagerstown, Md.)|November 27, 2001
Acadesine: a unique cardioprotective agent for myocardial ischemiaJ J Nawarskas
Heart Disease (Hagerstown, Md.)|April 27, 2002
Bivalirudin: a new approach to anticoagulationJ J Nawarskas, J R Anderson
Pharmacotherapy|June 15, 2000
Update on the interaction between aspirin and angiotensin-converting enzyme inhibitorsJ J Nawarskas, S A Spinler
The Annals of Pharmacotherapy|October 31, 2000
Vitamin C in the prevention of nitrate toleranceT A Daniel, J J Nawarskas
Pharmacotherapy|October 3, 1998
Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?J J Nawarskas, S A Spinler
Heart Disease (Hagerstown, Md.)|December 1, 2001
Omapatrilat: a unique new agent for the treatment of cardiovascular diseaseJ J Nawarskas, J R Anderson
The Annals of Pharmacotherapy|February 26, 1998
Low-molecular-weight heparins for acute coronary syndromesS A Spinler, J J Nawarskas
Cardiology Clinics|June 16, 2001
Cardiovascular drug-drug interactionsJ R Anderson, J J Nawarskas
Heart Disease (Hagerstown, Md.)|April 27, 2002
Ranolazine: a potential new treatment for chronic stable anginaJ R Anderson, S Khou, J J Nawarskas
The Annals of Pharmacotherapy|July 1, 1994
Misadventures with activated charcoal and recommendations for safe useL S Mauro, J J Nawarskas, V F Mauro
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Heart Disease (Hagerstown, Md.)|November 27, 2001
Acadesine: a unique cardioprotective agent for myocardial ischemiaJ J Nawarskas
Heart Disease (Hagerstown, Md.)|April 27, 2002
Bivalirudin: a new approach to anticoagulationJ J Nawarskas, J R Anderson
Pharmacotherapy|June 15, 2000
Update on the interaction between aspirin and angiotensin-converting enzyme inhibitorsJ J Nawarskas, S A Spinler
The Annals of Pharmacotherapy|October 31, 2000
Vitamin C in the prevention of nitrate toleranceT A Daniel, J J Nawarskas
Pharmacotherapy|October 3, 1998
Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?J J Nawarskas, S A Spinler
Heart Disease (Hagerstown, Md.)|December 1, 2001
Omapatrilat: a unique new agent for the treatment of cardiovascular diseaseJ J Nawarskas, J R Anderson
The Annals of Pharmacotherapy|February 26, 1998
Low-molecular-weight heparins for acute coronary syndromesS A Spinler, J J Nawarskas
Cardiology Clinics|June 16, 2001
Cardiovascular drug-drug interactionsJ R Anderson, J J Nawarskas
Heart Disease (Hagerstown, Md.)|April 27, 2002
Ranolazine: a potential new treatment for chronic stable anginaJ R Anderson, S Khou, J J Nawarskas
The Annals of Pharmacotherapy|July 1, 1994
Misadventures with activated charcoal and recommendations for safe useL S Mauro, J J Nawarskas, V F Mauro
Pageof 2